Liankang Sun
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 15
- MicroRNA in disease regulation 9
- Cancer, Hypoxia, and Metabolism 7
- Geriatrics and Gerontology top 5%
- Oncology top 5%
- Cancer Cells and Metastasis 9
- Pancreatic and Hepatic Oncology Research 9
- Molecular Biology top 5%
- RNA modifications and cancer 9
- Circular RNAs in diseases 7
- Hepatology top 5%
- Liver physiology and pathology 6
- Co-authors
- Yufeng WangBowen YaoQingyong MaKangsheng TuLiang WangZhikui LiuTianxiang ChenQingguang Liu
- Journals
- Oncology Reports (5 papers)Journal of Experimental & Clinical Cancer Research (5 papers)Biomedicine & Pharmacotherapy (4 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Liankang Sun
52 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 996
- Geriatrics and Gerontology 91
- Oncology 606
- Molecular Biology 1.4k
- Hepatology 126
Countries citing papers authored by Liankang Sun
This map shows the geographic impact of Liankang Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liankang Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liankang Sun more than expected).
Fields of papers citing papers by Liankang Sun
This network shows the impact of papers produced by Liankang Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liankang Sun. The network helps show where Liankang Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liankang Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 5 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 59 | |
| 8 | 2021 | 8 | |
| 9 | 2021 | 46 | |
| 10 | 2021 | 42 | |
| 11 | 2020 | 35 | |
| 12 | 2020 | 72 | |
| 13 | 2020 | 30 | |
| 14 | 2019 | 58 | |
| 15 | 2019 | 31 | |
| 16 | 2019 | 21 | |
| 17 | 2018 | 69 | |
| 18 | 2018 | 61 | |
| 19 | 2018 | 44 | |
| 20 | 2018 | 68 |
About Liankang Sun
Liankang Sun is a scholar working on Cancer Research, Hepatology and Oncology, having authored 55 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (9 papers), Cancer Cells and Metastasis (9 papers), Pancreatic and Hepatic Oncology Research (9 papers), RNA modifications and cancer (9 papers), Cancer, Hypoxia, and Metabolism (7 papers), Circular RNAs in diseases (7 papers) and Liver physiology and pathology (6 papers). The work is most often cited by research in Cancer Research (996 citations), Geriatrics and Gerontology (91 citations) and Oncology (606 citations). Liankang Sun has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Yufeng Wang, Bowen Yao, Qingyong Ma, Kangsheng Tu, Liang Wang, Zhikui Liu, Tianxiang Chen, Qingguang Liu, Zhengdong Jiang and Ke Chen. Their work appears in journals such as Oncology Reports, Journal of Experimental & Clinical Cancer Research, Biomedicine & Pharmacotherapy, Cell Death and Disease and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.